- Home
- CRBU vs CIVB Comparison
CRBU vs CIVB Comparison
Compare CRBU & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- CIVB
- Stock Information
- Founded
- CRBU 2011
- CIVB 1884
- Country
- CRBU United States
- CIVB United States
- Employees
- CRBU N/A
- CIVB N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- CIVB Major Banks
- Sector
- CRBU Health Care
- CIVB Finance
- Exchange
- CRBU Nasdaq
- CIVB Nasdaq
- Market Cap
- CRBU 236.3M
- CIVB 274.6M
- IPO Year
- CRBU 2021
- CIVB N/A
- Fundamental
- Price
- CRBU $2.00
- CIVB $22.90
- Analyst Decision
- CRBU Strong Buy
- CIVB Buy
- Analyst Count
- CRBU 3
- CIVB 4
- Target Price
- CRBU $14.00
- CIVB $19.67
- AVG Volume (30 Days)
- CRBU 1.9M
- CIVB 74.6K
- Earning Date
- CRBU 11-06-2024
- CIVB 10-29-2024
- Dividend Yield
- CRBU N/A
- CIVB 2.79%
- EPS Growth
- CRBU N/A
- CIVB N/A
- EPS
- CRBU N/A
- CIVB 2.00
- Revenue
- CRBU $11,475,000.00
- CIVB $146,565,000.00
- Revenue This Year
- CRBU N/A
- CIVB N/A
- Revenue Next Year
- CRBU N/A
- CIVB $6.04
- P/E Ratio
- CRBU N/A
- CIVB $11.46
- Revenue Growth
- CRBU N/A
- CIVB N/A
- 52 Week Low
- CRBU $1.50
- CIVB $13.60
- 52 Week High
- CRBU $8.33
- CIVB $23.70
- Technical
- Relative Strength Index (RSI)
- CRBU 43.48
- CIVB 72.21
- Support Level
- CRBU $2.37
- CIVB $21.78
- Resistance Level
- CRBU $2.08
- CIVB $23.01
- Average True Range (ATR)
- CRBU 0.26
- CIVB 0.80
- MACD
- CRBU -0.07
- CIVB -0.07
- Stochastic Oscillator
- CRBU 6.42
- CIVB 76.26
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.